Top Earners Under Review by NIH

Researchers with millions of grant dollars may face greater scrutiny by the funding agency.

Written byCristina Luiggi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, IMAGES_OF_MONEY

In an attempt to improve an all-time low grant success rate, the National Institutes of Health is considering submitting researchers earning top money to an extra step of the grant review process. According to Nature, researchers receiving more than $1.5 million in grant money—which amounts to roughly 5 percent of grant holders or 1,500 principal investigators—will be placed under higher scrutiny by the funding agency before approving new grants.

While the measure could both ensure the productivity of researchers handling multimillion dollar budgets, as well as potentially allow less-established researchers a slice of the money, some are worried about moving away from a purely merit-based system. “It’s a huge sea change,” Howard Garrison, director of public affairs at the Federation of American Societies for Experimental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery